[DOI] [PubMed] [Google Scholar] 87.Ferguson J.N., Young L.J., Insel T.R
Managing side effects during your protocol Gastrointestinal effects represent the primary tolerability concern with retatrutide
Research suggests BPC-157 may upregulate the expression of growth hormone receptors and interact with the FAK-paxillin pathway, which plays a role in cell adhesion and migration
PMID: 29756566 View source Stupnisek M, et al
Ethics declarations Ethics approval and consent to participate Not applicable Consent for publication Not applicable Competing interests All authors have read the journals authorship agreement and policy on disclosure of potential competing interest
BPC 157 in HumansClinical Trials and Current Use in Clinical Practice To date, BPC 157 pentadecapeptide has not been prescribed as a drug, though it is widely accessible on the black market